Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 22582208)

1.

Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?

Nelson KE.

Am J Epidemiol. 2012 Jun 1;175(11):1129-32. doi: 10.1093/aje/kws194. Epub 2012 May 11.

2.

[Guillain-Barré syndrome after exposure to influenza].

Hartung HP, Keller-Stanislawski B, Hughes RA, Lehmann HC.

Nervenarzt. 2012 Jun;83(6):714-30. doi: 10.1007/s00115-012-3479-8. Review. German.

PMID:
22528062
3.

Guillain-Barré syndrome after exposure to influenza virus.

Lehmann HC, Hartung HP, Kieseier BC, Hughes RA.

Lancet Infect Dis. 2010 Sep;10(9):643-51. doi: 10.1016/S1473-3099(10)70140-7. Review.

PMID:
20797646
4.

Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Israeli E, Agmon-Levin N, Blank M, Chapman J, Shoenfeld Y.

Clin Rev Allergy Immunol. 2012 Apr;42(2):121-30. doi: 10.1007/s12016-010-8213-3. Review.

PMID:
20890797
5.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
6.

Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.

Iskander J, Broder K.

Expert Rev Vaccines. 2008 Feb;7(1):75-82. doi: 10.1586/14760584.7.1.75. Review.

PMID:
18251695
7.

[Guillain-Barré syndrome secondary to H1N1 influenza vaccine].

López Nieto M, Gómez Garrido J, Losa Palacios A, Aguila Manso G.

Rev Clin Esp. 2010 Oct;210(9):485-6. doi: 10.1016/j.rce.2010.05.003. Epub 2010 Sep 15. Review. Spanish. No abstract available.

PMID:
20832792
8.
9.
10.

Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature.

Cortese A, Baldanti F, Tavazzi E, Carnevale L, Minoli L, Lozza A, Marchioni E.

J Neurol Sci. 2012 Jan 15;312(1-2):173-6. doi: 10.1016/j.jns.2011.08.047. Epub 2011 Oct 13. Review.

PMID:
22000408
11.

Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.

Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N; H1N1 Working Group of Federal Immunization Safety Task Force.

Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Epub 2011 Apr 18. Review.

12.

Vaccines and Guillain-Barré syndrome.

Haber P, Sejvar J, Mikaeloff Y, DeStefano F.

Drug Saf. 2009;32(4):309-23. doi: 10.2165/00002018-200932040-00005. Review.

PMID:
19388722
13.

[Influenza, an existing public health problem].

García-García J, Ramos C.

Salud Publica Mex. 2006 May-Jun;48(3):244-67. Review. Spanish.

14.

[Literature review on adverse events following immunization for influenza virus vaccine].

Bau HH, Li L, Wu WD.

Zhongguo Yi Miao He Mian Yi. 2009 Dec;15(6):547-53. Review. Chinese.

PMID:
20518336
15.

Safety of influenza vaccines.

Kelso JM.

Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):383-8. doi: 10.1097/ACI.0b013e328354395d. Review.

PMID:
22766619
16.

[National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].

Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-Pochat MC, Kreft-Jaïs C, Castot A, Damase-Michel C, Montastruc JL; le réseau français des centres de pharmacovigilance.

Therapie. 2011 Nov-Dec;66(6):527-40. doi: 10.2515/therapie/2011075. Epub 2011 Dec 21. Review. French.

PMID:
22186078
17.

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, Jackson LA, Omer SB, Jacobsen SJ, DeStefano F.

Vaccine. 2014 Sep 22;32(42):5390-8. doi: 10.1016/j.vaccine.2014.07.073. Epub 2014 Aug 6. Review.

PMID:
25108215
18.

Update on Guillain-Barré syndrome.

Rinaldi S.

J Peripher Nerv Syst. 2013 Jun;18(2):99-112. doi: 10.1111/jns5.12020. Review.

PMID:
23781958
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk